TABLE 2.
Primary and secondary outcomes
| Outcomea | Valueb for study group with a MIC of: |
P value | |
|---|---|---|---|
| <2 μg/ml (n = 91) | 2 μg/ml (n = 75) | ||
| 30-day in-hospital mortality | 12 (13.2) | 18 (24) | 0.072 |
| Persistent bacteremia | 15 (16.5) | 13 (17.3) | 0.884 |
| Duration of bacteremia (days) (median [IQR]) | 3.5 (2–6) | 4 (2–6) | 0.679 |
| Recurrence within 30 days | 9 (9.9) | 6 (8) | 0.672 |
| Change to alternative antibiotic therapy | 24 (26.4) | 24 (32) | 0.426 |
| Hospital LOS (days) (median [IQR]) | 16 (11–32) | 18 (11–32) | 0.759 |
a
IQR, interquartile range; LOS, length of stay.
b
Values are numbers (percentages) of patients with the indicated variable except where otherwise indicated.